Medplus Health Services Limited — Updates, 14-03-2026: General Updates
14-03-2026 | 02:31 pm
14-03-2026 | 02:31 pm
MedPlus subsidiary Optival faced temporary drug license suspensions for three stores (2-7 days each). This operational setback could lead to a total potential revenue loss of Rs 0.0479 Cr. Investors should watch for any wider impact.
No comments yet. Be the first to comment!
